中图分类号 R969.4；R972 文献标志码 A 文章编号 1001-0408(2025)10-1216-05

    DOI 10.6039/j.issn.1001-0408.2025.10.11

    Effects of alirocumab combined with atorvastatin on clinical efficacy and safety in patients with acute coronary syndrome after PCI

    HAO Cuijun，WANG Rui，MA Yiping，ZHANG Xueping，LIU Yanan，QIN Shaoqiang(Dept. of Cardiology，the First Affiliated Hospital of Hebei North University，Hebei Zhangjiakou 075000，China)

    ABSTRACT OBJECTIVE To investigate the effects of alirocumab combined with atorvastatin on clinical efficacy and safety of patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention(PCI). METHODS A total of 207 patients with ACS who underwent PCI in our hospital from January 2021 to December 2023 were randomly divided into alirocumab group，ezetimibe group and control group，with 69 cases in each group. All patients received routine thrombosis prevention and antihypertensive treatment after PCI. On this basis ......